Xenetic Biosciences, Inc. (XBIO)
4.20
-0.08
(-1.87%)
USD |
NASDAQ |
Sep 09, 16:00
4.20
0.00 (0.00%)
After-Hours: 17:10
Xenetic Biosciences Total Assets (Quarterly) : 6.968M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.968M |
| March 31, 2026 | 7.909M |
| December 31, 2025 | 8.364M |
| September 30, 2025 | 5.068M |
| June 30, 2025 | 5.354M |
| March 31, 2025 | 5.791M |
| December 31, 2024 | 6.901M |
| September 30, 2024 | 8.046M |
| June 30, 2024 | 9.033M |
| March 31, 2024 | 9.394M |
| December 31, 2023 | 10.61M |
| September 30, 2023 | 11.96M |
| June 30, 2023 | 12.75M |
| March 31, 2023 | 13.72M |
| December 31, 2022 | 14.72M |
| September 30, 2022 | 15.57M |
| June 30, 2022 | 16.47M |
| March 31, 2022 | 17.98M |
| December 31, 2021 | 19.82M |
| September 30, 2021 | 21.29M |
| June 30, 2021 | 10.92M |
| March 31, 2021 | 11.76M |
| December 31, 2020 | 13.18M |
| September 30, 2020 | 8.696M |
| June 30, 2020 | 19.06M |
| Date | Value |
|---|---|
| March 31, 2020 | 20.63M |
| December 31, 2019 | 21.55M |
| September 30, 2019 | 22.88M |
| June 30, 2019 | 15.63M |
| March 31, 2019 | 16.46M |
| December 31, 2018 | 14.43M |
| September 30, 2018 | 15.53M |
| June 30, 2018 | 17.26M |
| March 31, 2018 | 17.54M |
| December 31, 2017 | 19.16M |
| September 30, 2017 | 14.64M |
| June 30, 2017 | 16.44M |
| March 31, 2017 | 18.83M |
| December 31, 2016 | 20.97M |
| September 30, 2016 | 13.87M |
| June 30, 2016 | 13.16M |
| March 31, 2016 | 18.36M |
| December 31, 2015 | 16.91M |
| September 30, 2015 | 14.25M |
| June 30, 2015 | 13.27M |
| March 31, 2015 | 14.04M |
| December 31, 2014 | 16.32M |
| September 30, 2014 | 19.32M |
| June 30, 2014 | 23.05M |
| March 31, 2014 | 25.87M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 14.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.895M |
| Shareholders Equity (Quarterly) | 6.073M |
| Current Ratio | 7.435 |